\BOOKMARK [0][-]{section*.4}{Glossary}{}% 1
\BOOKMARK [0][-]{section*.6}{Acronyms}{}% 2
\BOOKMARK [0][-]{chapter.1}{Introduction and Literature Review}{}% 3
\BOOKMARK [1][-]{section.1.1}{Cancer Research in the Post-Genomic Era}{chapter.1}% 4
\BOOKMARK [2][-]{subsection.1.1.1}{Cancer is a Global Health Issue}{section.1.1}% 5
\BOOKMARK [3][-]{subsubsection.1.1.1.1}{The Genetics and Molecular Biology of Cancers}{subsection.1.1.1}% 6
\BOOKMARK [2][-]{subsection.1.1.2}{The Genomics Revolution in Cancer Research}{section.1.1}% 7
\BOOKMARK [3][-]{subsubsection.1.1.2.1}{High-Throughput Technologies}{subsection.1.1.2}% 8
\BOOKMARK [3][-]{subsubsection.1.1.2.2}{Bioinformatics and Genomics Data}{subsection.1.1.2}% 9
\BOOKMARK [2][-]{subsection.1.1.3}{Genomics Projects}{section.1.1}% 10
\BOOKMARK [3][-]{subsubsection.1.1.3.1}{The Cancer Genome Project}{subsection.1.1.3}% 11
\BOOKMARK [3][-]{subsubsection.1.1.3.2}{The Cancer Genome Atlas Project}{subsection.1.1.3}% 12
\BOOKMARK [2][-]{subsection.1.1.4}{Genomic Cancer Medicine}{section.1.1}% 13
\BOOKMARK [3][-]{subsubsection.1.1.4.1}{Cancer Genes and Driver Mutations}{subsection.1.1.4}% 14
\BOOKMARK [3][-]{subsubsection.1.1.4.2}{Precision Cancer Medicine}{subsection.1.1.4}% 15
\BOOKMARK [3][-]{subsubsection.1.1.4.3}{Molecular Diagnostics and Pan-Cancer Medicine}{subsection.1.1.4}% 16
\BOOKMARK [3][-]{subsubsection.1.1.4.4}{Targeted Therapeutics and Pharmacogenomics}{subsection.1.1.4}% 17
\BOOKMARK [2][-]{subsection.1.1.5}{Systems and Network Biology}{section.1.1}% 18
\BOOKMARK [3][-]{subsubsection.1.1.5.1}{Network Medicine and Polypharmacology}{subsection.1.1.5}% 19
\BOOKMARK [1][-]{section.1.2}{A Synthetic Lethal Approach to Cancer Medicine}{chapter.1}% 20
\BOOKMARK [2][-]{subsection.1.2.1}{Synthetic Lethal Genetic Interactions}{section.1.2}% 21
\BOOKMARK [2][-]{subsection.1.2.2}{Synthetic Lethal Concepts in Genetics}{section.1.2}% 22
\BOOKMARK [2][-]{subsection.1.2.3}{Studies of Synthetic Lethality}{section.1.2}% 23
\BOOKMARK [3][-]{subsubsection.1.2.3.1}{Synthetic Lethal Pathways and Networks}{subsection.1.2.3}% 24
\BOOKMARK [3][-]{subsubsection.1.2.3.2}{Evolution of Synthetic Lethality}{subsection.1.2.3}% 25
\BOOKMARK [2][-]{subsection.1.2.4}{Synthetic Lethal Concepts in Cancer}{section.1.2}% 26
\BOOKMARK [2][-]{subsection.1.2.5}{Clinical Impact of Synthetic Lethality in Cancer}{section.1.2}% 27
\BOOKMARK [2][-]{subsection.1.2.6}{High-throughput Screening for Synthetic Lethality}{section.1.2}% 28
\BOOKMARK [3][-]{subsubsection.1.2.6.1}{Synthetic Lethal Screens}{subsection.1.2.6}% 29
\BOOKMARK [2][-]{subsection.1.2.7}{Computational Prediction of Synthetic Lethality}{section.1.2}% 30
\BOOKMARK [3][-]{subsubsection.1.2.7.1}{Bioinformatics Approaches to Genetic Interactions}{subsection.1.2.7}% 31
\BOOKMARK [3][-]{subsubsection.1.2.7.2}{Comparative Genomics}{subsection.1.2.7}% 32
\BOOKMARK [3][-]{subsubsection.1.2.7.3}{Analysis and Modelling of Protein Data}{subsection.1.2.7}% 33
\BOOKMARK [3][-]{subsubsection.1.2.7.4}{Differential Gene Expression}{subsection.1.2.7}% 34
\BOOKMARK [3][-]{subsubsection.1.2.7.5}{Data Mining and Machine Learning}{subsection.1.2.7}% 35
\BOOKMARK [3][-]{subsubsection.1.2.7.6}{Bimodality}{subsection.1.2.7}% 36
\BOOKMARK [3][-]{subsubsection.1.2.7.7}{Rationale for Further Development}{subsection.1.2.7}% 37
\BOOKMARK [1][-]{section.1.3}{E-cadherin as a Synthetic Lethal Target}{chapter.1}% 38
\BOOKMARK [2][-]{subsection.1.3.1}{The CDH1 gene and its Biological Functions}{section.1.3}% 39
\BOOKMARK [3][-]{subsubsection.1.3.1.1}{Cytoskeleton}{subsection.1.3.1}% 40
\BOOKMARK [3][-]{subsubsection.1.3.1.2}{Extracellular and Tumour Micro-environment}{subsection.1.3.1}% 41
\BOOKMARK [3][-]{subsubsection.1.3.1.3}{Cell-Cell Adhesion and Signalling}{subsection.1.3.1}% 42
\BOOKMARK [2][-]{subsection.1.3.2}{CDH1 as a Tumour \(and Invasion\) Suppressor}{section.1.3}% 43
\BOOKMARK [3][-]{subsubsection.1.3.2.1}{Breast Cancers and Invasion}{subsection.1.3.2}% 44
\BOOKMARK [2][-]{subsection.1.3.3}{Hereditary Diffuse Gastric Cancer and Lobular Breast Cancer}{section.1.3}% 45
\BOOKMARK [2][-]{subsection.1.3.4}{Models of CDH1 loss in cell lines}{section.1.3}% 46
\BOOKMARK [1][-]{section.1.4}{Summary and Research Direction of Thesis}{chapter.1}% 47
\BOOKMARK [2][-]{subsection.1.4.1}{Thesis Aims}{section.1.4}% 48
\BOOKMARK [0][-]{subsection.1.4.1}{References}{}% 190
